Decisions for lung cancer chemotherapy: The influence of physician and patient factors

Patricia M Davidson, Moyez Jiwa, Alice J. Goldsmith, Sarah J. McGrath, Michelle Digiacomo, Jane L. Phillips, Meera Agar, Phillip J. Newton, David C. Currow

Research output: Contribution to journalArticle

Abstract

Purpose: The purpose of this study is to review the literature examining how the beliefs and behaviours of physicians and patients influence clinical communication, doctor-patient interaction and treatment decisions for lung cancer treatment. Methods: Literature was obtained via electronic database searches and hand searching of journals from 1990 to 2011. Results: Wide variability in perceptions of the value of chemotherapy in lung cancer is present among both physicians and patients. There is a mismatch in the degree patients and physicians weigh survival, such that patients value survival benefits highly whilst physicians strongly emphasize toxicity and associated symptoms. This lack of congruence between patients and clinicians is influenced by a range of factors and has implications for treatment decisions, long-term survival and quality of life in people affected by lung cancer. Conclusion: The divergence of treatment priorities indicates a need for improved communication strategies addressing the needs and concerns of both patients and clinicians. Patients should understand the benefits and risks of treatment options, while clinicians can gain a greater awareness of factors influencing patients' decisions on treatments. Reflecting these perspectives and patient preferences for lung cancer treatment in clinical guidelines may improve clinician awareness.

Original languageEnglish (US)
Pages (from-to)1261-1266
Number of pages6
JournalSupportive Care in Cancer
Volume19
Issue number8
DOIs
StatePublished - Aug 2011
Externally publishedYes

Fingerprint

Lung Neoplasms
Physicians
Drug Therapy
Therapeutics
Survival
Communication
Patient Preference
Quality of Life
Databases
Guidelines

Keywords

  • Chemotherapy
  • Decision-making
  • Lung cancer
  • Patient preference

ASJC Scopus subject areas

  • Oncology

Cite this

Davidson, P. M., Jiwa, M., Goldsmith, A. J., McGrath, S. J., Digiacomo, M., Phillips, J. L., ... Currow, D. C. (2011). Decisions for lung cancer chemotherapy: The influence of physician and patient factors. Supportive Care in Cancer, 19(8), 1261-1266. https://doi.org/10.1007/s00520-011-1176-y

Decisions for lung cancer chemotherapy : The influence of physician and patient factors. / Davidson, Patricia M; Jiwa, Moyez; Goldsmith, Alice J.; McGrath, Sarah J.; Digiacomo, Michelle; Phillips, Jane L.; Agar, Meera; Newton, Phillip J.; Currow, David C.

In: Supportive Care in Cancer, Vol. 19, No. 8, 08.2011, p. 1261-1266.

Research output: Contribution to journalArticle

Davidson, PM, Jiwa, M, Goldsmith, AJ, McGrath, SJ, Digiacomo, M, Phillips, JL, Agar, M, Newton, PJ & Currow, DC 2011, 'Decisions for lung cancer chemotherapy: The influence of physician and patient factors', Supportive Care in Cancer, vol. 19, no. 8, pp. 1261-1266. https://doi.org/10.1007/s00520-011-1176-y
Davidson, Patricia M ; Jiwa, Moyez ; Goldsmith, Alice J. ; McGrath, Sarah J. ; Digiacomo, Michelle ; Phillips, Jane L. ; Agar, Meera ; Newton, Phillip J. ; Currow, David C. / Decisions for lung cancer chemotherapy : The influence of physician and patient factors. In: Supportive Care in Cancer. 2011 ; Vol. 19, No. 8. pp. 1261-1266.
@article{63ba47a3a98b4dcfbbe180e9f0fc51cb,
title = "Decisions for lung cancer chemotherapy: The influence of physician and patient factors",
abstract = "Purpose: The purpose of this study is to review the literature examining how the beliefs and behaviours of physicians and patients influence clinical communication, doctor-patient interaction and treatment decisions for lung cancer treatment. Methods: Literature was obtained via electronic database searches and hand searching of journals from 1990 to 2011. Results: Wide variability in perceptions of the value of chemotherapy in lung cancer is present among both physicians and patients. There is a mismatch in the degree patients and physicians weigh survival, such that patients value survival benefits highly whilst physicians strongly emphasize toxicity and associated symptoms. This lack of congruence between patients and clinicians is influenced by a range of factors and has implications for treatment decisions, long-term survival and quality of life in people affected by lung cancer. Conclusion: The divergence of treatment priorities indicates a need for improved communication strategies addressing the needs and concerns of both patients and clinicians. Patients should understand the benefits and risks of treatment options, while clinicians can gain a greater awareness of factors influencing patients' decisions on treatments. Reflecting these perspectives and patient preferences for lung cancer treatment in clinical guidelines may improve clinician awareness.",
keywords = "Chemotherapy, Decision-making, Lung cancer, Patient preference",
author = "Davidson, {Patricia M} and Moyez Jiwa and Goldsmith, {Alice J.} and McGrath, {Sarah J.} and Michelle Digiacomo and Phillips, {Jane L.} and Meera Agar and Newton, {Phillip J.} and Currow, {David C.}",
year = "2011",
month = "8",
doi = "10.1007/s00520-011-1176-y",
language = "English (US)",
volume = "19",
pages = "1261--1266",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - Decisions for lung cancer chemotherapy

T2 - The influence of physician and patient factors

AU - Davidson, Patricia M

AU - Jiwa, Moyez

AU - Goldsmith, Alice J.

AU - McGrath, Sarah J.

AU - Digiacomo, Michelle

AU - Phillips, Jane L.

AU - Agar, Meera

AU - Newton, Phillip J.

AU - Currow, David C.

PY - 2011/8

Y1 - 2011/8

N2 - Purpose: The purpose of this study is to review the literature examining how the beliefs and behaviours of physicians and patients influence clinical communication, doctor-patient interaction and treatment decisions for lung cancer treatment. Methods: Literature was obtained via electronic database searches and hand searching of journals from 1990 to 2011. Results: Wide variability in perceptions of the value of chemotherapy in lung cancer is present among both physicians and patients. There is a mismatch in the degree patients and physicians weigh survival, such that patients value survival benefits highly whilst physicians strongly emphasize toxicity and associated symptoms. This lack of congruence between patients and clinicians is influenced by a range of factors and has implications for treatment decisions, long-term survival and quality of life in people affected by lung cancer. Conclusion: The divergence of treatment priorities indicates a need for improved communication strategies addressing the needs and concerns of both patients and clinicians. Patients should understand the benefits and risks of treatment options, while clinicians can gain a greater awareness of factors influencing patients' decisions on treatments. Reflecting these perspectives and patient preferences for lung cancer treatment in clinical guidelines may improve clinician awareness.

AB - Purpose: The purpose of this study is to review the literature examining how the beliefs and behaviours of physicians and patients influence clinical communication, doctor-patient interaction and treatment decisions for lung cancer treatment. Methods: Literature was obtained via electronic database searches and hand searching of journals from 1990 to 2011. Results: Wide variability in perceptions of the value of chemotherapy in lung cancer is present among both physicians and patients. There is a mismatch in the degree patients and physicians weigh survival, such that patients value survival benefits highly whilst physicians strongly emphasize toxicity and associated symptoms. This lack of congruence between patients and clinicians is influenced by a range of factors and has implications for treatment decisions, long-term survival and quality of life in people affected by lung cancer. Conclusion: The divergence of treatment priorities indicates a need for improved communication strategies addressing the needs and concerns of both patients and clinicians. Patients should understand the benefits and risks of treatment options, while clinicians can gain a greater awareness of factors influencing patients' decisions on treatments. Reflecting these perspectives and patient preferences for lung cancer treatment in clinical guidelines may improve clinician awareness.

KW - Chemotherapy

KW - Decision-making

KW - Lung cancer

KW - Patient preference

UR - http://www.scopus.com/inward/record.url?scp=80051580274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051580274&partnerID=8YFLogxK

U2 - 10.1007/s00520-011-1176-y

DO - 10.1007/s00520-011-1176-y

M3 - Article

C2 - 21614670

AN - SCOPUS:80051580274

VL - 19

SP - 1261

EP - 1266

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 8

ER -